ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Administration Seeks Increase In FDA Budget.

June 13, 2008

Three researchers share Paul Marks Prize.

November 11, 2005

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Alcohol Consumption Does Not Impact Survival of Breast Cancer

April 26, 2013